IBDEI08A ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10884,1,4,0)
 ;;=4^173.10
 ;;^UTILITY(U,$J,358.3,10884,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,10885,0)
 ;;=173.11^^73^698^53
 ;;^UTILITY(U,$J,358.3,10885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10885,1,3,0)
 ;;=3^Eyelid/Canthus,BCC
 ;;^UTILITY(U,$J,358.3,10885,1,4,0)
 ;;=4^173.11
 ;;^UTILITY(U,$J,358.3,10885,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,10886,0)
 ;;=173.12^^73^698^57
 ;;^UTILITY(U,$J,358.3,10886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10886,1,3,0)
 ;;=3^Eyelid/Canthus,SCC
 ;;^UTILITY(U,$J,358.3,10886,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,10886,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,10887,0)
 ;;=173.19^^73^698^55
 ;;^UTILITY(U,$J,358.3,10887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10887,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Oth
 ;;^UTILITY(U,$J,358.3,10887,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,10887,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,10888,0)
 ;;=053.20^^73^698^51
 ;;^UTILITY(U,$J,358.3,10888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10888,1,3,0)
 ;;=3^Eyelid,Herpes Zoster
 ;;^UTILITY(U,$J,358.3,10888,1,4,0)
 ;;=4^053.20
 ;;^UTILITY(U,$J,358.3,10888,2)
 ;;=^56937
 ;;^UTILITY(U,$J,358.3,10889,0)
 ;;=054.41^^73^698^50
 ;;^UTILITY(U,$J,358.3,10889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10889,1,3,0)
 ;;=3^Eyelid,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,10889,1,4,0)
 ;;=4^054.41
 ;;^UTILITY(U,$J,358.3,10889,2)
 ;;=^266563
 ;;^UTILITY(U,$J,358.3,10890,0)
 ;;=078.0^^73^698^77
 ;;^UTILITY(U,$J,358.3,10890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10890,1,3,0)
 ;;=3^Molluscum Contagiosum
 ;;^UTILITY(U,$J,358.3,10890,1,4,0)
 ;;=4^078.0
 ;;^UTILITY(U,$J,358.3,10890,2)
 ;;=^78675
 ;;^UTILITY(U,$J,358.3,10891,0)
 ;;=228.1^^73^698^76
 ;;^UTILITY(U,$J,358.3,10891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10891,1,3,0)
 ;;=3^Lymphangioma
 ;;^UTILITY(U,$J,358.3,10891,1,4,0)
 ;;=4^228.1
 ;;^UTILITY(U,$J,358.3,10891,2)
 ;;=^72391
 ;;^UTILITY(U,$J,358.3,10892,0)
 ;;=238.2^^73^698^3
 ;;^UTILITY(U,$J,358.3,10892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10892,1,3,0)
 ;;=3^Benign Neopl,Oth & Unspec Sites/Tissue
 ;;^UTILITY(U,$J,358.3,10892,1,4,0)
 ;;=4^238.2
 ;;^UTILITY(U,$J,358.3,10892,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,10893,0)
 ;;=242.00^^73^698^61
 ;;^UTILITY(U,$J,358.3,10893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10893,1,3,0)
 ;;=3^Goiter Toxic Dif/Graves Thyrotoxic Exoph
 ;;^UTILITY(U,$J,358.3,10893,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,10893,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,10894,0)
 ;;=272.2^^73^698^101
 ;;^UTILITY(U,$J,358.3,10894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10894,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,10894,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,10894,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,10895,0)
 ;;=360.40^^73^698^60
 ;;^UTILITY(U,$J,358.3,10895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10895,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,10895,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,10895,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,10896,0)
 ;;=360.42^^73^698^65
 ;;^UTILITY(U,$J,358.3,10896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10896,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,10896,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,10896,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,10897,0)
 ;;=360.89^^73^698^59
 ;;^UTILITY(U,$J,358.3,10897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10897,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,10897,1,4,0)
 ;;=4^360.89
 ;;^UTILITY(U,$J,358.3,10897,2)
 ;;=^268581
 ;;^UTILITY(U,$J,358.3,10898,0)
 ;;=373.01^^73^698^5
 ;;^UTILITY(U,$J,358.3,10898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10898,1,3,0)
 ;;=3^Blepharitis,Ulcerative
 ;;^UTILITY(U,$J,358.3,10898,1,4,0)
 ;;=4^373.01
 ;;^UTILITY(U,$J,358.3,10898,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,10899,0)
 ;;=373.31^^73^698^49
 ;;^UTILITY(U,$J,358.3,10899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10899,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,10899,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,10899,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,10900,0)
 ;;=373.34^^73^698^52
 ;;^UTILITY(U,$J,358.3,10900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10900,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,10900,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,10900,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,10901,0)
 ;;=373.9^^73^698^37
 ;;^UTILITY(U,$J,358.3,10901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10901,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,10901,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,10901,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,10902,0)
 ;;=374.21^^73^698^75
 ;;^UTILITY(U,$J,358.3,10902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10902,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,10902,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,10902,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,10903,0)
 ;;=374.22^^73^698^74
 ;;^UTILITY(U,$J,358.3,10903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10903,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,10903,1,4,0)
 ;;=4^374.22
 ;;^UTILITY(U,$J,358.3,10903,2)
 ;;=^269093
 ;;^UTILITY(U,$J,358.3,10904,0)
 ;;=374.23^^73^698^73
 ;;^UTILITY(U,$J,358.3,10904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10904,1,3,0)
 ;;=3^Lagophthalmos,Cicatricial
 ;;^UTILITY(U,$J,358.3,10904,1,4,0)
 ;;=4^374.23
 ;;^UTILITY(U,$J,358.3,10904,2)
 ;;=^269095
 ;;^UTILITY(U,$J,358.3,10905,0)
 ;;=374.31^^73^698^42
 ;;^UTILITY(U,$J,358.3,10905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10905,1,3,0)
 ;;=3^Eyelid Ptosis,Paralytic
 ;;^UTILITY(U,$J,358.3,10905,1,4,0)
 ;;=4^374.31
 ;;^UTILITY(U,$J,358.3,10905,2)
 ;;=^269097
 ;;^UTILITY(U,$J,358.3,10906,0)
 ;;=374.32^^73^698^41
 ;;^UTILITY(U,$J,358.3,10906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10906,1,3,0)
 ;;=3^Eyelid Ptosis,Myogenic
 ;;^UTILITY(U,$J,358.3,10906,1,4,0)
 ;;=4^374.32
 ;;^UTILITY(U,$J,358.3,10906,2)
 ;;=^269098
 ;;^UTILITY(U,$J,358.3,10907,0)
 ;;=374.33^^73^698^40
 ;;^UTILITY(U,$J,358.3,10907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10907,1,3,0)
 ;;=3^Eyelid Ptosis,Mechanical
 ;;^UTILITY(U,$J,358.3,10907,1,4,0)
 ;;=4^374.33
 ;;^UTILITY(U,$J,358.3,10907,2)
 ;;=^269099
 ;;^UTILITY(U,$J,358.3,10908,0)
 ;;=374.34^^73^698^26
 ;;^UTILITY(U,$J,358.3,10908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10908,1,3,0)
 ;;=3^Eyelid Blepharochalasis/Pseudoptosis
 ;;^UTILITY(U,$J,358.3,10908,1,4,0)
 ;;=4^374.34
 ;;^UTILITY(U,$J,358.3,10908,2)
 ;;=^15275
 ;;^UTILITY(U,$J,358.3,10909,0)
 ;;=374.41^^73^698^44
 ;;^UTILITY(U,$J,358.3,10909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10909,1,3,0)
 ;;=3^Eyelid Retraction/Lag
 ;;^UTILITY(U,$J,358.3,10909,1,4,0)
 ;;=4^374.41
 ;;^UTILITY(U,$J,358.3,10909,2)
 ;;=^269101
 ;;^UTILITY(U,$J,358.3,10910,0)
 ;;=374.43^^73^698^25
 ;;^UTILITY(U,$J,358.3,10910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10910,1,3,0)
 ;;=3^Eyelid Abn Innervation Synd
 ;;^UTILITY(U,$J,358.3,10910,1,4,0)
 ;;=4^374.43
 ;;^UTILITY(U,$J,358.3,10910,2)
 ;;=^269102
 ;;^UTILITY(U,$J,358.3,10911,0)
 ;;=374.46^^73^698^27
 ;;^UTILITY(U,$J,358.3,10911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10911,1,3,0)
 ;;=3^Eyelid Blepharophimosis
 ;;^UTILITY(U,$J,358.3,10911,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,10911,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,10912,0)
 ;;=374.50^^73^698^30
 ;;^UTILITY(U,$J,358.3,10912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10912,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
 ;;^UTILITY(U,$J,358.3,10912,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,10912,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,10913,0)
 ;;=374.52^^73^698^34
 ;;^UTILITY(U,$J,358.3,10913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10913,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,10913,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,10913,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,10914,0)
 ;;=374.53^^73^698^36
 ;;^UTILITY(U,$J,358.3,10914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10914,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,10914,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,10914,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,10915,0)
 ;;=374.54^^73^698^35
 ;;^UTILITY(U,$J,358.3,10915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10915,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,10915,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,10915,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,10916,0)
 ;;=374.56^^73^698^39
 ;;^UTILITY(U,$J,358.3,10916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10916,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,10916,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,10916,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,10917,0)
 ;;=374.81^^73^698^33
 ;;^UTILITY(U,$J,358.3,10917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10917,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,10917,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,10917,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,10918,0)
 ;;=374.82^^73^698^32
 ;;^UTILITY(U,$J,358.3,10918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10918,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,10918,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,10918,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,10919,0)
 ;;=374.85^^73^698^45
 ;;^UTILITY(U,$J,358.3,10919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10919,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,10919,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,10919,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,10920,0)
 ;;=374.86^^73^698^38
 ;;^UTILITY(U,$J,358.3,10920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10920,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,10920,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,10920,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,10921,0)
 ;;=376.11^^73^698^89
 ;;^UTILITY(U,$J,358.3,10921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10921,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
